SBIA
GILD icon

Sheaff Brock Investment Advisors’s Gilead Sciences GILD Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 450

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sheaff Brock Investment Advisors's GILD Position: Q1 2025 in Review

Sheaff Brock Investment Advisors opened a new position in Gilead Sciences (GILD) in Q1 2025: 2,299 shares worth $258K. The stake represents 0.02% of the portfolio and ranks #355 among its holdings. This is a return to the name: Sheaff Brock Investment Advisors previously reported a position in GILD as recently as Q2 2024.

Sheaff Brock Investment Advisors first reported a position in GILD in Q4 2015 and has held it in 36 quarters since. The position peaked at $5.37M in Q4 2015. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Sheaff Brock Investment Advisors held 2,299 shares of Gilead Sciences worth $258K as of Q1 2025.
  • Gilead Sciences was a new Sheaff Brock Investment Advisors position in Q1 2025.
  • Gilead Sciences made up 0.02% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #355 holding.
  • Sheaff Brock Investment Advisors first reported a position in Gilead Sciences in Q4 2015 and has held it in 36 quarters since.
  • Sheaff Brock Investment Advisors's Gilead Sciences position peaked at $5.37M in Q4 2015.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.